Research has shown that METTL3, a methyltransferase or “writer”, acts primarily as an oncogene in several cancers including breast cancer, leukemia, glioblastoma, and more, but has also been shown to have a role as a tumor suppressor in cancers such as renal cell carcinoma and bladder cancer [84]. Here, METTL3 is linked to cancer.